Support for RGS4 as a susceptibility gene for schizophrenia

Biological Psychiatry

Volumn 55, Issue 2, 2004, Pages 192-195

  Williams, Nigel M ^a   Preece, Anna ^a   Spurlock, Gillian ^a   Norton, Nadine ^a   Williams, Hywel J ^a   McCreadie, Robin G ^b   Buckland, Paul ^a   Sharkey, Val ^b   Chowdari, Kodavali V ^c   Zammit, Stanley ^a   Nimgaonkar, Vishwajit ^c   Kirov, George ^a   Owen, Michael J ^a   O'Donovan, Michael C ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Crichton Royal Hospital   (United Kingdom)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Association; Candidate gene; Haplotype; Promoter; Reporter gene; Schizophrenia

Indexed keywords

REGULATOR OF G PROTEIN SIGNALING 4 PROTEIN; RGS PROTEIN; UNCLASSIFIED DRUG; ALANINE; GLYCINE; MESSENGER RNA; RGS4 PROTEIN; THREONINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGULATOR OF G PROTEIN SIGNALING 4 GENE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; ALLELE; BIOSYNTHESIS; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; METHODOLOGY; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ALANINE; ALLELES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLYCINE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RGS PROTEINS; RNA, MESSENGER; SCHIZOPHRENIA; THREONINE;

EID: 12144286093     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2003.11.002     Document Type: Article

References (27)

1. Bray N.J., Buckland P.R., Williams N.M., Williams H.J., Norton N., Owen M.J., et al. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet. 73:2003;152-161.
2. Brustowicz L.M., Hodgkinson K.A., Chow E.W., Honer W.G., Bassett A.S. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science. 288:2000;678-682.
3. Chen X., Levine L., Kwok P.Y. Fluorescence polarization in homogenous nucleic acid analysis. Genome Res. 9:1999;492-498.
4. Chowdari K.V., Mirnics K., Semwal P., Wood J., Lawrence E., Bhatia T., et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet. 11:(12):2002;1373-1380.
5. Druey K.M., Blumer K.J., Kang V.H., Kehrl J.H. Inhibition of G protein-mediated MAP kinase activation by a new mammalian gene family. Nature. 379:(6567):1996;742-746.
6. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A. 98:2001;4746-4751.
7. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cézard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:2001;599-603.
8. Ioannidis J.P.A., Ntzani E.E., Trikalinos T.A., Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet. 29:(3):2001;306-309.
9. Mirnics K., Middleton F.A., Lewis D.A., Levitt P. Analysis of complex brain disorders with gene expression microarrays Schizophrenia as a disease of the synapse. Trends Neurosci. 24:2001;479-486.
10. Mirnics K., Middleton F.A., Stanwood G.D., Lewis D.A., Levitt P. Disease-specific changes in regulator of G-protein signalling 4 (RGS4) expression in schizophrenia. Mol Psychiatry. 6:2001;293-301.
11. O'Donovan M.C., Owen M.J. Candidate gene association studies of schizophrenia. Am J Hum Genet. 65:1999;587-592.
12. Owen M.J., Holmans P., McGuffin P. Association studies in psychiatric genetics. Mol Psychiatry. 2:1997;270-273.
13. Schwab S., Knapp M., Mondabon S., Hallmayer J., Borrmann-Hassenbach M., Albus M., et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet. 72:2003;185-190.
14. Stefansson H., Sarginson J., Kong A., Yates P., Steinthorsdottir V., Gudfinnsson E., et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet. 72:2003;83-87.
15. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 71:2002;877-892.
16. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet. 71:2002;337-348.
17. Taymans J.M., Leysen J.E., Langlois X. Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors Clues for RGS2 and RGS4 functions. J Neurochem. 84:2003;1118-1127.
18. Teng J., Risch N. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases. II. Individual genotyping. Genome Res. 9:(3):1999;234-241.
19. Thaminy S., Auerbach D., Arnoldo A., Stagljar I. Identification of novel ErbB3-interacting factors using the split-ubiquitin membrane yeast two-hybrid system. Genome Res. 13:2003;1744-1753.
20. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 362:2003;798-805.
21. University of Pittsburgh (2003): Information concerning the RGS4 gene. Available at: http://www.pitt.edu/AFShome/n/i/nimga/public/html/research/RGS4/ Accessed on November 2, 2003.
22. Williams N.M., Rees M.I., Holmans P., Norton N., Cardno A.G., Jones L.A., et al. A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs. Hum Mol Genet. 8:(9):1999;1729-1739.
23. Williams, N.M., Preece, A., Morris, D.W., Spurlock, G., Bray, N.J., Stephens, M., et al (2003): Confirmation in two independent samples that dystobrevin binding protein (DTNBP1) is a susceptibility locus for schizophrenia. Arch Gen Psychiatry.
24. Williams N.M., Preece A., Spurlock G., Norton N., Williams H.J., Zammit S., et al. Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol Psychiatry. 8:2003;485-487.
25. Wing J.K., Babor T., Brugha T. SCAN Schedules for the clinical assessment in neuropsychiatry. Arch Gen Psychiatry. 47:1990;589-593.
26. Wing J.K., Cooper J.E., Satorius N. The Measurement and Classification of Psychiatric Illness. 1974;Cambridge University Press, Cambridge, MA.
27. Zhao J., Curtis D., Sham P.C. Model-free analysis and permutation test for allelic associations. Hum Hered. 50:2000;133-139.